Press Release / Media Release
Press Release Regarding Lincoln Pharmaceuticals Limited Awarded Patent for "Antimalarial Drug"19-12-2017
19-12-2017
Outcome of Board Meeting
The Board of Directors of the Company at their meeting held today, i.e. on Tuesday, December 12, 2017 had considered and approved the Un-audited Consolidated and Standalone Financial Results of the Company for the Quarter/half year ended on 30th September, 2017. The Un-audited Consolidated and Standalone Financial Results along with Limited Review Report of the Statutory Auditors for the Quarter ended on 30th September, 2017 are attached herewith.12-12-2017
Financial Results For September 30, 2017.
The Board of Directors of the Company at their meeting held today, i.e. on Tuesday, December 12, 2017 had considered and approved the Un-audited Consolidated and Standalone Financial Results of the Company for the Quarter/half year ended on 30th September, 2017. The Un-audited Consolidated and Standalone Financial Results along with Limited Review Report of the Statutory Auditors for the Quarter ended on 30th September, 2017 are attached herewith.12-12-2017
Board Meeting On December 12, 2017
Intimation regarding Meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, December 12, 2017 at the Registered Office of the Company inter-alia to consider and approve the Un-Audited Consolidated and Standalone Financial Results of the Company for the Quarter and Half Year Ended on September 30, 201727-11-2017
Updates
Submission of Newspaper Advertisement regarding notice for transfer of Equity Shares to IEPF Authority for last 7 consecutive years06-11-2017
Minutes Of The 23Rd Annual General Meeting Of The Company.
Enclosed herewith the minutes of the 23rd Annual General Meeting of the Company held on Friday, 29th September, 2017 at 10.30 a.m. at "LINCOLN HOUSE", Behind Satyam Complex, Science City Road, Sola, Ahmedabad- 380009.24-10-2017
Updates
Intimation regarding incorporation of Wholly Owned Subsidiary Company of Lincoln Pharmaceuticals Limited18-10-2017
Shareholding for the Period Ended September 30, 2017
Lincoln Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2017. For more details, kindly Click here17-10-2017
Certificate From PCS Under Reg. 40 (9) Of SEBI (LODR) Reg., 2015
Certificate from Practicing Company Secretary for the half year ended on September 30, 2017 under Reg. 40 (9) of SEBI (LODR) Reg., 201516-10-2017
Statement Of Investor Complaints For The Quarter Ended On September 30, 2017
Statement of Investor Complaints for the three months ended on September 30, 201712-10-2017